Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Antibody Persistence of Menitorix Booster
NCT00454987Phase 4Completed
- Sponsor
- GSK
- Start
- May 2007
- Primary completion
- Oct 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 4 trial of Hib-MenC-TT in Haemophilus influenzae type b infection (Hib), Meningococcal disease serogroup C (MenC), sponsored by GSK. Started May 2007; status: completed.
02
Drugs
Hib-MenC-TT
03
Conditions
Haemophilus influenzae type b infection (Hib)Meningococcal disease serogroup C (MenC)
Beyond the preview
Go deeper on NCT00454987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454987.